Neurology Minute

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss practical approaches to genetic adrenoleukodystrophy. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192  

In the first part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss red flag symptoms that suggest the need for genetic testing in patients with white matter disease. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457

Dr. Rae Bacharach discusses the Neurology Today article, “Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com.  Show reference: https://journals.lww.com/neurotodayonline/pages/default.aspx https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964 

In the final part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss what you need to know about analyzing network meta-analysis. Show reference: https://www.bmj.com/content/386/bmj-2024-080107  

Drs. Justin Abbatemarco, Marius Ringelstein, and Ilya Ayzenberg discuss a new class of complement inhibitors that we're using in NMOSD. Show reference: https://www.neurology.org/doi/full/10.1212/WNL.0000000000209888

In part two of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss clinical pearls on how to select an acute treatment plan for migraine. Show reference: https://www.bmj.com/content/386/bmj-2024-080107 

In the first part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani explain the significance of this study and how its findings can be applied in clinical practice. Show reference: https://www.bmj.com/content/386/bmj-2024-080107 

Dr. Jodie Roberts and Dr. Amra Sakusic discusses the relationship between reversal therapy and ischemic stroke, between duration off anticoagulation and risk of ischemic strokes or systemic embolism. Learn more about the Neurology Practice Current section and fill out the survey now. Show reference: https://survey.alchemer.com/s3/7969148/Practice-Current-When-do-you-start-anticoagulation-therapy-for-patients-with-both-ICH-and-AF https://www.neurology.org/doi/10.1212/WNL.0000000000209664

In this Women's History Minute, Dr. Alison Christy discusses the Cajal School of Neuropathology in Spain and emphasizes the importance of mentorship.

Dr. Greg Cooper and Dr. Clifford R. Jack Jr. discuss objective criteria for diagnosis and staging Alzheimer disease, highlighting recent advancements in biomarkers to bridge the gap between research and clinical practice.  Show reference: https://pubmed.ncbi.nlm.nih.gov/38934362/ 

Dr. Gordon Smith and Dr. Whitley Aamodt discuss end-of-life care for patients with neurodegenerative diseases, focusing on healthcare utilization, hospice enrollment, and the importance of early conversations about care preferences. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209925    

Dr. Alison Christy delves into another women's history minute to discuss Cecile Vogt.

Dr. Jason Crowell talks about Neurology on the Hill and how you can get involved if you are interested. Show reference: https://www.aan.com/policy-and-guidelines/capitol-hill-report/ 

Dr. Halley Alexander discusses the Neurology Today article, "A Comparison of Side Effects for Four First-line Antiseizure Medications" by Stacey Burling, available in the September 19th issue of Neurology Today or at neurologytoday.com.  Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09190/a_comparison_of_side_effects_for_four_first_line.1.aspx

Dr. Kait Nevel and Dr. Oumaima Aboubakr discuss the prevalence of epilepsy in primary CNS lymphoma. Show reference:  https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209748 

In the final part of this three-part series, Drs. Stacey Clardy, Elisabeth Bik, and Matthew Schrag discuss how to uphold research integrity. Show reference:  https://undark.org/2024/09/11/the-rise-of-the-science-sleuths/   

Dr. Stacey Clardy discusses why B vitamins matter in neurology in this lab minute. 

Dr. Stacey Clardy discusses what to check instead of ACE levels if you suspect a diagnosis of sarcoidosis in this lab minute.  

Dr. Rae Bacharach talks with Dr. Manon Auffret about her NeuroByte titled, "How to Respond to a Request for Hastened Death from a Person Living with Neurologic Illness".  Show reference: https://learning.aan.com/courses/74069

In part two of this series, Drs. Stacey Clardy, Elisabeth Bik, and Matthew Schrag discuss the best ways that we as neurology clinicians and researchers can help to actively prevent fraud. Show references: https://undark.org/2024/09/11/the-rise-of-the-science-sleuths/